COVID-19 Impact on Global Arginase Deficiency Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: C57D2C3BB4A5EN
QYResearch

Abstracts

This report focuses on the global Arginase Deficiency Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Arginase Deficiency Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Helsinn Healthcare
• Novartis Pharmaceuticals
• Horizo??n Pharma
• Medicis Pharmaceutical
• ...

Market segment by Type, the product can be split into

• Oral
• Injection

Market segment by Application, split into

• Hospital
• Drugs Stores
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Arginase Deficiency Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Arginase Deficiency Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Arginase Deficiency Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Arginase Deficiency Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Arginase Deficiency Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Injection
1.5 Market by Application
  1.5.1 Global Arginase Deficiency Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Drugs Stores
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Arginase Deficiency Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Arginase Deficiency Treatment Industry
    1.6.1.1 Arginase Deficiency Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Arginase Deficiency Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Arginase Deficiency Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Arginase Deficiency Treatment Market Perspective (2015-2026)
2.2 Arginase Deficiency Treatment Growth Trends by Regions
  2.2.1 Arginase Deficiency Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Arginase Deficiency Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Arginase Deficiency Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Arginase Deficiency Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Arginase Deficiency Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Arginase Deficiency Treatment Players by Market Size
  3.1.1 Global Top Arginase Deficiency Treatment Players by Revenue (2015-2020)
  3.1.2 Global Arginase Deficiency Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Arginase Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Arginase Deficiency Treatment Market Concentration Ratio
  3.2.1 Global Arginase Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Arginase Deficiency Treatment Revenue in 2019
3.3 Arginase Deficiency Treatment Key Players Head office and Area Served
3.4 Key Players Arginase Deficiency Treatment Product Solution and Service
3.5 Date of Enter into Arginase Deficiency Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Arginase Deficiency Treatment Historic Market Size by Type (2015-2020)
4.2 Global Arginase Deficiency Treatment Forecasted Market Size by Type (2021-2026)

5 ARGINASE DEFICIENCY TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Arginase Deficiency Treatment Market Size by Application (2015-2020)
5.2 Global Arginase Deficiency Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Arginase Deficiency Treatment Market Size (2015-2020)
6.2 Arginase Deficiency Treatment Key Players in North America (2019-2020)
6.3 North America Arginase Deficiency Treatment Market Size by Type (2015-2020)
6.4 North America Arginase Deficiency Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Arginase Deficiency Treatment Market Size (2015-2020)
7.2 Arginase Deficiency Treatment Key Players in Europe (2019-2020)
7.3 Europe Arginase Deficiency Treatment Market Size by Type (2015-2020)
7.4 Europe Arginase Deficiency Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Arginase Deficiency Treatment Market Size (2015-2020)
8.2 Arginase Deficiency Treatment Key Players in China (2019-2020)
8.3 China Arginase Deficiency Treatment Market Size by Type (2015-2020)
8.4 China Arginase Deficiency Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Arginase Deficiency Treatment Market Size (2015-2020)
9.2 Arginase Deficiency Treatment Key Players in Japan (2019-2020)
9.3 Japan Arginase Deficiency Treatment Market Size by Type (2015-2020)
9.4 Japan Arginase Deficiency Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Arginase Deficiency Treatment Market Size (2015-2020)
10.2 Arginase Deficiency Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Arginase Deficiency Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Arginase Deficiency Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Arginase Deficiency Treatment Market Size (2015-2020)
11.2 Arginase Deficiency Treatment Key Players in India (2019-2020)
11.3 India Arginase Deficiency Treatment Market Size by Type (2015-2020)
11.4 India Arginase Deficiency Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Arginase Deficiency Treatment Market Size (2015-2020)
12.2 Arginase Deficiency Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Arginase Deficiency Treatment Market Size by Type (2015-2020)
12.4 Central & South America Arginase Deficiency Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Helsinn Healthcare
  13.1.1 Helsinn Healthcare Company Details
  13.1.2 Helsinn Healthcare Business Overview and Its Total Revenue
  13.1.3 Helsinn Healthcare Arginase Deficiency Treatment Introduction
  13.1.4 Helsinn Healthcare Revenue in Arginase Deficiency Treatment Business (2015-2020))
  13.1.5 Helsinn Healthcare Recent Development
13.2 Novartis Pharmaceuticals
  13.2.1 Novartis Pharmaceuticals Company Details
  13.2.2 Novartis Pharmaceuticals Business Overview and Its Total Revenue
  13.2.3 Novartis Pharmaceuticals Arginase Deficiency Treatment Introduction
  13.2.4 Novartis Pharmaceuticals Revenue in Arginase Deficiency Treatment Business (2015-2020)
  13.2.5 Novartis Pharmaceuticals Recent Development
13.3 Horizo??n Pharma
  13.3.1 Horizo??n Pharma Company Details
  13.3.2 Horizo??n Pharma Business Overview and Its Total Revenue
  13.3.3 Horizo??n Pharma Arginase Deficiency Treatment Introduction
  13.3.4 Horizo??n Pharma Revenue in Arginase Deficiency Treatment Business (2015-2020)
  13.3.5 Horizo??n Pharma Recent Development
13.4 Medicis Pharmaceutical
  13.4.1 Medicis Pharmaceutical Company Details
  13.4.2 Medicis Pharmaceutical Business Overview and Its Total Revenue
  13.4.3 Medicis Pharmaceutical Arginase Deficiency Treatment Introduction
  13.4.4 Medicis Pharmaceutical Revenue in Arginase Deficiency Treatment Business (2015-2020)
  13.4.5 Medicis Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Arginase Deficiency Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Arginase Deficiency Treatment Revenue
Table 3. Ranking of Global Top Arginase Deficiency Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Arginase Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injection
Table 7. COVID-19 Impact Global Market: (Four Arginase Deficiency Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Arginase Deficiency Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Arginase Deficiency Treatment Players to Combat Covid-19 Impact
Table 12. Global Arginase Deficiency Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Arginase Deficiency Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Arginase Deficiency Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Arginase Deficiency Treatment Market Share by Regions (2015-2020)
Table 16. Global Arginase Deficiency Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Arginase Deficiency Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Arginase Deficiency Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Arginase Deficiency Treatment Players
Table 23. Global Arginase Deficiency Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Arginase Deficiency Treatment Market Share by Players (2015-2020)
Table 25. Global Top Arginase Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arginase Deficiency Treatment as of 2019)
Table 26. Global Arginase Deficiency Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Arginase Deficiency Treatment Product Solution and Service
Table 29. Date of Enter into Arginase Deficiency Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Arginase Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Arginase Deficiency Treatment Market Size Share by Type (2015-2020)
Table 33. Global Arginase Deficiency Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Arginase Deficiency Treatment Market Size Share by Application (2015-2020)
Table 35. Global Arginase Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Arginase Deficiency Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Arginase Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Arginase Deficiency Treatment Market Share (2019-2020)
Table 39. North America Arginase Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Arginase Deficiency Treatment Market Share by Type (2015-2020)
Table 41. North America Arginase Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Arginase Deficiency Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Arginase Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Arginase Deficiency Treatment Market Share (2019-2020)
Table 45. Europe Arginase Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Arginase Deficiency Treatment Market Share by Type (2015-2020)
Table 47. Europe Arginase Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Arginase Deficiency Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Arginase Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Arginase Deficiency Treatment Market Share (2019-2020)
Table 51. China Arginase Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Arginase Deficiency Treatment Market Share by Type (2015-2020)
Table 53. China Arginase Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Arginase Deficiency Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Arginase Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Arginase Deficiency Treatment Market Share (2019-2020)
Table 57. Japan Arginase Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Arginase Deficiency Treatment Market Share by Type (2015-2020)
Table 59. Japan Arginase Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Arginase Deficiency Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Arginase Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Arginase Deficiency Treatment Market Share (2019-2020)
Table 63. Southeast Asia Arginase Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Arginase Deficiency Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Arginase Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Arginase Deficiency Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Arginase Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Arginase Deficiency Treatment Market Share (2019-2020)
Table 69. India Arginase Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Arginase Deficiency Treatment Market Share by Type (2015-2020)
Table 71. India Arginase Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Arginase Deficiency Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Arginase Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Arginase Deficiency Treatment Market Share (2019-2020)
Table 75. Central & South America Arginase Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Arginase Deficiency Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Arginase Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Arginase Deficiency Treatment Market Share by Application (2015-2020)
Table 79. Helsinn Healthcare Company Details
Table 80. Helsinn Healthcare Business Overview
Table 81. Helsinn Healthcare Product
Table 82. Helsinn Healthcare Revenue in Arginase Deficiency Treatment Business (2015-2020) (Million US$)
Table 83. Helsinn Healthcare Recent Development
Table 84. Novartis Pharmaceuticals Company Details
Table 85. Novartis Pharmaceuticals Business Overview
Table 86. Novartis Pharmaceuticals Product
Table 87. Novartis Pharmaceuticals Revenue in Arginase Deficiency Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Pharmaceuticals Recent Development
Table 89. Horizo??n Pharma Company Details
Table 90. Horizo??n Pharma Business Overview
Table 91. Horizo??n Pharma Product
Table 92. Horizo??n Pharma Revenue in Arginase Deficiency Treatment Business (2015-2020) (Million US$)
Table 93. Horizo??n Pharma Recent Development
Table 94. Medicis Pharmaceutical Company Details
Table 95. Medicis Pharmaceutical Business Overview
Table 96. Medicis Pharmaceutical Product
Table 97. Medicis Pharmaceutical Revenue in Arginase Deficiency Treatment Business (2015-2020) (Million US$)
Table 98. Medicis Pharmaceutical Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Arginase Deficiency Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Arginase Deficiency Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Drugs Stores Case Studies
Figure 7. Other Case Studies
Figure 8. Arginase Deficiency Treatment Report Years Considered
Figure 9. Global Arginase Deficiency Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Arginase Deficiency Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Arginase Deficiency Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Arginase Deficiency Treatment Market Share by Players in 2019
Figure 14. Global Top Arginase Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arginase Deficiency Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Arginase Deficiency Treatment Revenue in 2019
Figure 16. North America Arginase Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Arginase Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Arginase Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Arginase Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Arginase Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Arginase Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Arginase Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Helsinn Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Helsinn Healthcare Revenue Growth Rate in Arginase Deficiency Treatment Business (2015-2020)
Figure 25. Novartis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novartis Pharmaceuticals Revenue Growth Rate in Arginase Deficiency Treatment Business (2015-2020)
Figure 27. Horizo??n Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Horizo??n Pharma Revenue Growth Rate in Arginase Deficiency Treatment Business (2015-2020)
Figure 29. Medicis Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Medicis Pharmaceutical Revenue Growth Rate in Arginase Deficiency Treatment Business (2015-2020)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed